CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in OCGN — Ocugen, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$383,890
+$152,064 QoQ
Shares Held
212,094
+23.5% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $5,925,631,926 across 288 Biotechnology names. OCGN ranks #222 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in OCGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $383,890 | 212,094 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $231,826 | 171,723 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $279,908 | 171,723 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $166,571 | 171,723 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $607,332 | 860,244 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $692,496 | 860,244 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $760,820 | 766,956 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,202,824 | 776,016 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $279,216 | 170,254 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $97,896 | 170,254 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $68,101 | 170,254 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $615,772 | 1,134,020 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,295,560 | 1,518,828 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,106,397 | 1,620,306 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,774,094 | 1,558,480 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,456,381 | 1,522,635 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,655,973 | 1,410,901 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,239,082 | 1,371,227 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,701,041 | 1,351,120 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,753,687 | 467,458 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $463,600 | 68,277 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||